AMGN · Amgen Inc · Executive Compensation
$465.67
-1.39 (-0.30%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$251.89B
Shares
540.91M
Volume · Nov 13
2.12M
Avg daily vol (3M)
2.79M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert Bradway | Chief Executive Officer and President | $24,428,495 |
| James E. Bradner | Executive Vice President, Research and Development | $14,914,381 |
| Murdo Gordon | Executive Vice President, Global Commercial Operations | $8,473,500 |
| David Reese | CTO | $8,126,822 |
| David M. Reese, M.D. | Executive Vice President, and Chief Technology Officer | $8,126,822 |
| Peter Griffith | Executive Vice President and Chief Financial Officer | $7,806,811 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Robert Bradway | Chief Executive Officer and President | $22,643,650 |
| Murdo Gordon | Executive Vice President, Global Commercial Operations | $8,242,811 |
| David M. Reese, M.D. | Executive Vice President, and Chief Technology Officer | $7,902,655 |
| David Reese | CTO | $7,902,655 |
| Peter Griffith | Executive Vice President and Chief Financial Officer | $7,569,298 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Robert Bradway | Chief Executive Officer and President | $21,399,733 |
| Murdo Gordon | Executive Vice President, Global Commercial Operations | $7,717,226 |
| David Reese | CTO | $7,333,124 |
| David M. Reese, M.D. | Executive Vice President, and Chief Technology Officer | $7,333,124 |
| Peter Griffith | Executive Vice President and Chief Financial Officer | $7,073,735 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Esteban Santos | Executive Vice President, Operations | $6,591,653 |
| Peter Griffith | Executive Vice President, and Chief Financial Officer | $6,565,830 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David W. Gibbs | director | Appointed | 2026-10-27 |
| Thomas Dittrich | executive vice president | Appointed | 2026-05-19 |
| Thomas Dittrich | Executive Vice President and Chief Financial Officer | Appointed | 2026-05-19 |
| Peter H. Griffith | Executive Vice President and Chief Financial Officer | Retired | 2026-05-19 |
| Sean Bruich | Senior Vice President, Chief Technology Officer | Appointed | 2026-04-22 |
| James E. Bradner | Executive Vice President, Research and Development, Artificial Intelligence and Data | Appointed | 2026-04-22 |
| David M. Reese | Executive Vice President | Retired | 2026-04-22 |
| David M. Reese | Executive Vice President and Chief Technology Officer | Retired | 2026-04-22 |
| James Bradner, M.D. | Executive Vice President, Research and Development, and Chief Scientific Officer | Appointed | 2023-12-14 |
| David M. Reese, M.D. | Executive Vice President and Chief Technology Officer | Appointed | 2023-12-14 |
| Matthew C. Busch | Vice President, Finance and Chief Accounting Officer | Appointed | 2023-08-04 |
| Michael V. Drake | director | Appointed | 2022-08-03 |
Leadership
- Robert Bradway CEO
- David W. Meline CFO
- Thomas Dittrich CFO
- David M. Reese, M.D. CTO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- David W. Gibbs Board Member
- Michael V. Drake Board Member
- S. Omar Ishrak Board Member
Key facts
CIK
318154
CUSIP
031162100
13F (30d)
2574 filings
2445 filers
Visit website
Investor relations